Dupilumab Beneficial for Adults With Prurigo Nodularis

WEDNESDAY, May 10, 2023 -- For adults with prurigo nodularis (PN), dupilumab, a fully human monoclonal antibody that blocks the shared receptor component for interleukin (IL)-4 and IL-13, demonstrates clinically meaningful and significant...